跳至主要内容
临床试验/NCT06111963
NCT06111963已完成不适用

Role of Inflammatory Markers Measured Using Flow Cytometry in the Diagnosis and Prognosis of Sepsis in Surgical Cancer Patients

National Cancer Institute, Egypt1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
To evaluate the expression IL17

研究概览

简要总结

A diagnostic and prognostic study, in which the expression of CD64 in activated neutrophils and CD64 and IL17A regulatory T cells in patients with sepsis will be evaluated as a probable marker for sepsis as a primary objective

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Cancer patients admitted to the surgical ICU following cancer related surgeries and diagnosed with sepsis

排除标准

  • Refusal of patient or patient guardian to participate.
  • Intraoperative massive blood loss and massive blood transfusion
  • Patients with impaired preoperative kidney or liver function tests

结局指标

主要结局

To evaluate the expression IL17

时间窗: 7 days

Serology

To evaluate the expression CD4

时间窗: 7 days

Serology

To evaluate the expression CD25

时间窗: 7 days

Serology

次要结局

未报告次要终点

研究者

发起方
National Cancer Institute, Egypt
申办方类型
Other
责任方
Principal Investigator
主要研究者

Walaa Youssef Elsabeeny

Assistant Professor of Anesthesia and Pain management

National Cancer Institute, Egypt

研究点 (1)

Loading locations...

相似试验

Role of Inflammatory Markers in Sepsis | 临床试验